A study strongly supports stereotactic radiation for up to 20 brain metastases, proving superior to even advanced whole-brain techniques and widely accessible.
Ayal Aizer, MD, MHS
Advertisement
Ayal Aizer, MD, MHS, is a brain radiation oncologist at Brigham and Women's Hospital and Dana-Farber Cancer Institute.
Articles by Ayal Aizer, MD, MHS
Ayal Aizer, MD, MHS, discusses the findings of a phase 3 study investigating the use of stereotactic radiation vs whole-brain radiation in patients with 5 to 20 brain metastases.
Ayal Aizer, MD, MHS, discusses the unmet needs in treating patients with brain metastases.
Advertisement
Latest Updated Articles
Aizer on Personalizing Radiation for Brain MetastasesPublished: May 28th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
